Tupperware Brands Corp
Change company Symbol lookup
Select an option...
TUP Tupperware Brands Corp
AKRO Akero Therapeutics Inc
MRTX Mirati Therapeutics Inc
SIRC Solar Integrated Roofing Corp
CHSTY China High Speed Transmission Equipment Group Co Ltd
TTMZF Datable Technology Corp
WVFC W V S Financial Corp
WHLM Wilhelmina International Inc
SON Sonoco Products Co
VIRX Viracta Therapeutics Inc

Consumer Discretionary : Household Durables | Small Cap Value
Company profile

Tupperware Brands Corporation is a global consumer products company. The Company is engaged in the marketing, manufacturing and selling design-centric preparation, storage, and serving solutions for the kitchen and home through the Tupperware brand name. The Company primarily designs functional products to help store, serve, and prepare food. The Company operates its business through four geographic regions: Asia Pacific, Europe (Europe, Africa and the Middle East), North America, and South America. Its Tupperware brand product line consists of cookware, knives, microwave products, microfiber textiles, water-filtration-related items, and an array of products for on-the-go consumers. Its products include XtremAqua Freezable Bottle, Universal Cookware set, SuperSonic Choppers and others. The Company distributes its products into approximately 70 countries primarily through independent representatives around the world.


Last Trade
-0.01 (-0.21%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children

7:20 am ET September 23, 2022 (MarketWatch)

Jaimy Lee

Plus, Moderna is 'eager' to sell its COVID-19 shot in China, and U.S. cases continue to decline.

A Food and Drug Administration official said this week that updated COVID-19 boosters for 5- to 11-year-olds will be authorized in the coming weeks, according to ABC News.

The new boosters developed by BioNTech (BNTX)/Pfizer (PFE) and Moderna (MRNA) protect against the original strain of the virus as well as the newer BA.4 and BA.5 subvariants, which make up about 85% of all cases worldwide right now.

"I'm confident that we're only a matter of weeks away," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said Tuesday at an event.

The shots are expected to roll out to different age groups much as have been seen before. They will likely be available first for 5- to 11-year-olds first and then for younger children.

That said, COVID-19 vaccine uptake for children has been low. Only about 9.3 million children younger than 12 years old are fully vaccinated. There are about 43 million children in the U.S. who are 10 years old or younger.

Other COVID-19 news to know:

-Jaimy Lee


(END) Dow Jones Newswires

September 23, 2022 07:20 ET (11:20 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.